Nava Health review

What it is

Nava Health is a functional and integrative medicine practice with centres in Ashburn and Fairfax, Virginia and Bethesda and Columbia, Maryland, plus telemedicine. Its peptide service is organised into five named categories rather than sold as one undifferentiated 'peptide therapy': recovery and healing (BPC-157, GHK-Cu, TB-500), muscle and strength (CJC-1295, IGF-1 LR3, tesamorelin), energy and metabolism (MOTS-c, SS-31, 5-Amino-1MQ), immune and longevity (thymosin alpha-1, epithalon) and brain, sleep and mood (semax, selank, DSIP, VIP). Around it sit hormone replacement, IV micronutrient and NAD⁺ IV therapy, diagnostic testing, gut health and a NavaRX medical weight-loss program using semaglutide and tirzepatide. Care comes from board-certified MDs, DOs, nurse practitioners, physician assistants and functional-medicine nutritionists.

How it works

Hybrid and lab-led: you can be seen in person at one of the four centres or by telemedicine, and the practice's whole pitch is that advanced biomarker testing drives the plan rather than a questionnaire. That is a genuinely different proposition from an async storefront, and for peptides — where dose, cycling and monitoring are unstandardised — having a clinician who ordered your labs is worth something. The structure to understand before you book is that Nava is à la carte and cash-based. Consults are priced individually even for members: a 30-minute new-client intake is listed at $100, a 30-minute functional-medicine consult at $200 and a 60-minute one at $400, with member rates below list. Lab panels are billed on top, from a comprehensive hormone panel up to a 90-plus-biomarker foundational panel and advanced gut and cardiovascular testing. Memberships are sold separately again, including a NavaRX membership listed around $111/month billed annually that buys lab access and coaching rather than medication. The telehealth state list is not published, so confirm eligibility before you plan around it.

Pricing transparency

There is no published peptide price, and we are not going to invent one. Nava publishes a detailed price list for consults, panels and memberships, so the omission is a choice about medication pricing rather than a site that publishes nothing — you can see what an intake and a hormone panel cost before you call, but not what a month of BPC-157 or CJC-1295 costs. Budget accordingly: on this model the total is a consult, plus labs, plus the medication, plus any membership, and only the first two are knowable in advance. Before your first appointment, ask what each named peptide costs per month, whether the price changes as the dose is titrated, whether follow-up consults during a cycle are billed again, and which panels are required rather than recommended. The $111/month figure that circulates for Nava is a membership covering lab access; treating it as a peptide price would be wrong.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The category-by-category menu is also an evidence ladder, and it runs steeply downhill. Tesamorelin is the strongest name on it: an FDA-approved growth-hormone-releasing factor analogue, though approved for HIV-associated lipodystrophy rather than the general body-composition use it is marketed for here. CJC-1295 is a GHRH analogue acting on the same real, well-described pituitary axis, with thin long-term human outcome data. BPC-157 has an interesting animal-model tendon and gut-healing literature and no controlled human outcome trials; GHK-Cu has essentially none behind its collagen claims; TB-500 is a synthetic thymosin beta-4 fragment studied almost entirely in animals. MOTS-c, SS-31, 5-Amino-1MQ, epithalon, semax, selank, DSIP and VIP sit further out again — mitochondrial and neuropeptide research compounds whose human evidence is preliminary at best, and several of which have no approved human formulation anywhere. Thymosin alpha-1 is approved in some countries outside the US. Nava's NAD⁺ IV therapy carries the same limitation as every injected NAD⁺ product: no controlled human outcome trials, while oral NR and NMN raise blood NAD⁺, a biomarker rather than a benefit. Individual results vary.

Pros and watch-outs

The evidence behind what Nava Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• BPC 157: what the evidence actually shows (and what it doesn't)

  The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.

• GHK-Cu: the copper peptide between real skincare and overclaim

  A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.

• Ipamorelin & CJC-1295: the honest evidence on GH secretagogue peptides

  They reliably raise growth hormone — that part is real. The muscle, fat-loss and anti-aging claims are not supported by human outcome data. A straight read.

• Tesamorelin (Egrifta): what it's actually FDA-approved for, and the evidence

  A real, approved GHRH analog — for HIV-associated lipodystrophy specifically. What the pivotal trials showed, and why the longevity use is an extrapolation.

• NAD+ IV therapy: an expensive drip ahead of its evidence

  Clinics sell NAD+ infusions for anti-aging, energy and addiction at $250–$1,500 a session — but there's no controlled trial of IV NAD+, and the real human evidence is for oral precursors, not the drip.

How Nava Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

• NHNuform Health

  Comparing injectable against oral NAD⁺ if you are willing to prepay in kits

  See Nuform Health →
• OWOnyx Weight Loss

  NAD⁺ from a named clinical team and a named pharmacy, if you live in one of its eight states

  See Onyx Weight Loss →
• NMNova MD

  NAD⁺ buyers who want the concentration and vial size stated, not just a monthly fee

  See Nova MD →